Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, March 30, 2020
[ Mon, Mar 30th 2020
] - WOPRAI
[ Mon, Mar 30th 2020
] - WOPRAI
[ Mon, Mar 30th 2020
] - WOPRAI
[ Mon, Mar 30th 2020
] - WOPRAI
Fri, March 27, 2020
[ Fri, Mar 27th 2020
] - WOPRAI
[ Fri, Mar 27th 2020
] - WOPRAI
[ Fri, Mar 27th 2020
] - WOPRAI
[ Fri, Mar 27th 2020
] - WOPRAI
[ Fri, Mar 27th 2020
] - WOPRAI
[ Fri, Mar 27th 2020
] - WOPRAI
[ Fri, Mar 27th 2020
] - WOPRAI
[ Fri, Mar 27th 2020
] - WOPRAI
[ Fri, Mar 27th 2020
] - WOPRAI
[ Fri, Mar 27th 2020
] - WOPRAI
[ Fri, Mar 27th 2020
] - WOPRAI
[ Fri, Mar 27th 2020
] - WOPRAI
[ Fri, Mar 27th 2020
] - WOPRAI
[ Fri, Mar 27th 2020
] - WOPRAI
[ Fri, Mar 27th 2020
] - WOPRAI
[ Fri, Mar 27th 2020
] - WOPRAI
[ Fri, Mar 27th 2020
] - WOPRAI
[ Fri, Mar 27th 2020
] - WOPRAI
[ Fri, Mar 27th 2020
] - WOPRAI
[ Fri, Mar 27th 2020
] - WOPRAI
[ Fri, Mar 27th 2020
] - WOPRAI
[ Fri, Mar 27th 2020
] - WOPRAI
[ Fri, Mar 27th 2020
] - WOPRAI
[ Fri, Mar 27th 2020
] - WOPRAI
[ Fri, Mar 27th 2020
] - WOPRAI
Madhu Kumar Maintained (VIR) at Sell with Increased Target to $20 on, Mar 27th, 2020
Madhu Kumar of Baird, Maintained "Vir Biotechnology, Inc." (VIR) at Sell with Increased Target from $17 to $20 on, Mar 27th, 2020.
Madhu has made no other calls on VIR in the last 4 months.
There are 2 other peers that have a rating on VIR. Out of the 2 peers that are also analyzing VIR, 1 agrees with Madhu's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Paul Choi of "Goldman Sachs" Downgraded from Strong Buy to Hold on, Friday, March 13th, 2020
This is the rating of the analyst that currently disagrees with Madhu
- Anupam Rama of "JP Morgan" Downgraded from Hold to Sell and Held Target at $26 on, Thursday, March 19th, 2020
